Clinical Trial Update: Biomarkers in Immunotherapy of Melanoma [NA]

View source ↗

Summary

A clinical trial update on biomarker research for immunotherapy in metastatic melanoma, including analyses of the gastrointestinal microbiome and exosomal PD-L1…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Institute of Oncology Ljubljana | Conditions: Metastatic Melanoma, Immune Checkpoints Inhibitors | NA | Status: RECRUITING